• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

News of the day

PR Newswire search

Most viewed

Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody

Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance

Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease

Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited

Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.

More recent news

CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Animated Video
11th November 2008 SARASOTA, Florida, November 11 /PRNewswire/ -- CPC of America, Inc. (CPC) (OTC Bulletin Board: CPCF), today launched its new Web site, www.CPCMedDevices.com, to provide the medical and...

InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces US$1.25 Million Private Placement
7th November 2008 BRITISH COLUMBIA, Canada, November 7 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX Venture: IXS; http://www.ixsbio.com), a drug development company commercializing the...

AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing
31st October 2008 PHILADELPHIA, October 31 /PRNewswire/ -- AVAX Technologies, Inc. (OTC Bulletin Board: AVXT) (the "Company") today announced that on October 24, 2008, it closed a bridge loan financing pursuant to a...

InNexus Biotechnology Receives Patent Grants in Europe
30th October 2008 BRITISH COLUMBIA, Canada, October 30 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the...

CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
29th October 2008 SARASOTA, Florida, October 29 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on the development of therapeutic devices for use in endovascular procedures,...

Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
29th October 2008 NOVATO, California, October 29 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced that senior management will present a corporate overview and clinical pipeline...

InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
28th October 2008 BRITISH COLUMBIA, Canada, October 28 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the...

CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System
24th October 2008 SARASOTA, Florida, October 24 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on developing therapeutic devices for use in endovascular procedures, announced today...

Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
20th October 2008 NOVATO, California, October 20 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the initiation of patient dosing in a Phase...

Senetek Affirms Strong Financial Position
13th October 2008 NAPA, California, October 13 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy...

CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
29th September 2008 SARASOTA, Florida, September 29 /PRNewswire/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of...

InNexus Biotechnology CEO to Present at BioContactQuebec 2008
29th September 2008 BRITISH COLUMBIA, Canada, September 29 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the...

St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership
19th September 2008 PHOENIX and BRITISH COLUMBIA, Canada, September 19 /PRNewswire/ -- St. Joseph's Hospital and Medical Center, part of Catholic Healthcare West, one of the largest healthcare systems in the West with...

InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
16th September 2008 BRITISH COLUMBIA, Canada, September 16 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX VENTURE: IXS; OTC Bulletin Board: IXSBF; http://www.ixsbio.com), a drug development company commercializing the...

InNexus Biotechnology Strengthens Patent Team With New Leadership
9th September 2008 BRITISH COLUMBIA, Canada, September 9 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, http://www.ixsbio.com), a drug development company commercializing the...

InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
8th September 2008 BRITISH COLUMBIA, Canada, September 8 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the...

Senetek Launches Pyratine-6(TM)
4th September 2008 NAPA, California, September 4 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy...

Senetek PLC Appoints Michael Rogers PR
3rd September 2008 NAPA, California, September 3 /PRNewswire/ -- Senetek PLC, a life sciences company dedicated to the development of advanced anti-aging technologies, today announced the appointment of Michael Rogers...

Senetek PLC Reports Second Quarter 2008 Financial Results
14th August 2008 NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
7th August 2008 BRITISH COLUMBIA, Canada, August 7 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the...

Global Med Technologies Announces Acquisition of eDonor(R): One of the Industry's Premier Technology Platforms for Donor Recruitment, Scheduling and Retention
1st August 2008 DENVER, August 1 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today...

Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease
31st July 2008 NEW YORK, July 31 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) announced today it has obtained a European patent relating to the Company's ANTISENILIN(R) monoclonal...

GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
22nd July 2008 ATLANTA and NANTES, France, July 22 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
16th July 2008 NOVATO, California, July 16 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement...

Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
14th July 2008 NOVATO, California, July 14 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of...

Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
3rd July 2008 NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
1st July 2008 NAPA, California, July 1 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
30th June 2008 NAPA, California, June 30 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Raptor Pharmaceuticals Closes U.S.$10 Million Private Placement
30th June 2008 NOVATO, California, June 30 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced that it raised U.S.$10 million through a private placement of 20 million units...

Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody
24th June 2008 NEW YORK, June 24 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) and MRC Technology (MRCT) announced today they have achieved an important milestone through their...

Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
23rd June 2008 NOVATO, California, June 23 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that Ted Daley, President of Raptor's...

Senetek PLC Announces Key Personnel Appointments
9th June 2008 NAPA, California, June 9 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
19th May 2008 NEW YORK, May 19 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment...

Senetek PLC Reports First Quarter 2008 Financial Results
15th May 2008 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Starpharma Reports Positive VivaGel(R) Clinical Study Results
12th May 2008 MELBOURNE, Australia, May 12 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating...

CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
24th April 2008 LAS VEGAS, April 24 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has entered into an agreement with Mr. Phillip Frey Jr. to form Cardio Derma Clinical Partners...

Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
21st April 2008 NOVATO, California, April 21 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that its clinical development subsidiary,...

Access Pharmaceuticals Announces New Data on Angiolix(R)
17th April 2008 DALLAS, April 17 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced results from preclinical studies ongoing at the prestigious Imperial College London on Angiolix(R),...

Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease
10th April 2008 NEW YORK, April 10 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), announced today that it has obtained a Notice of Allowance and completed the grant requirements to obtain...

Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance
9th April 2008 DENVER, April 9 /PRNewswire/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate...

Global Med Technologies(R), Inc. Signs Purchase Agreement to Acquire Inlog, SA, a European Medical Software Firm
31st March 2008 DENVER, March 31 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today...